BioMarin to Participate in Three Upcoming Investor Conferences
BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in three major investor conferences in November and December 2024. The company will present at the UBS Global Healthcare Conference on November 12 at 11:00 am PST, the Jefferies London Healthcare Conference on November 19 at 9:00 am GMT, and the 7th Annual Evercore ISI HealthCONx Conference on December 4 at 7:00 am PST.
Live audio webcasts of the presentations will be accessible through BioMarin's investor website, with archived versions available for -time replay.
BioMarin Pharmaceutical (NASDAQ: BMRN) ha annunciato la sua partecipazione a tre importanti conferenze per investitori a novembre e dicembre 2024. L'azienda presenterà alla UBS Global Healthcare Conference il 12 novembre alle 11:00 PST, alla Jefferies London Healthcare Conference il 19 novembre alle 9:00 GMT e alla 7a Conferenza Annuale Evercore ISI HealthCONx il 4 dicembre alle 7:00 PST.
I webcast audio in diretta delle presentazioni saranno disponibili sul sito web per investitori di BioMarin, con versioni archiviate accessibili per la riproduzione successiva.
BioMarin Pharmaceutical (NASDAQ: BMRN) ha anunciado su participación en tres importantes conferencias para inversores en noviembre y diciembre de 2024. La compañía presentará en la Conferencia Global de Salud de UBS el 12 de noviembre a las 11:00 a.m. PST, en la Conferencia de Salud de Jefferies en Londres el 19 de noviembre a las 9:00 a.m. GMT, y en la 7ª Conferencia Anual Evercore ISI HealthCONx el 4 de diciembre a las 7:00 a.m. PST.
Las transmisiones web de audio en vivo de las presentaciones estarán disponibles a través del sitio web de inversores de BioMarin, con versiones archivadas accesibles para reproducciones posteriores.
BioMarin Pharmaceutical (NASDAQ: BMRN)는 2024년 11월과 12월에 열리는 세 가지 주요 투자자 회의에 참여한다고 발표했습니다. 회사는 11월 12일 오전 11시 PST에 UBS 글로벌 헬스케어 컨퍼런스에서, 11월 19일 오전 9시 GMT에 제프리스 런던 헬스케어 컨퍼런스에서, 그리고 12월 4일 오전 7시 PST에 제7회 에버코어 ISI HealthCONx 컨퍼런스에서 발표할 예정입니다.
발표의 라이브 오디오 웹캐스트는 BioMarin의 투자자 웹사이트를 통해 접근 가능하며, 아카이브된 버전은 나중에 다시 재생할 수 있습니다.
BioMarin Pharmaceutical (NASDAQ: BMRN) a annoncé sa participation à trois importantes conférences pour investisseurs en novembre et décembre 2024. L'entreprise présentera à la Conférence mondiale sur la santé d'UBS le 12 novembre à 11h00 PST, à la Conférence sur la santé de Jefferies à Londres le 19 novembre à 9h00 GMT, et à la 7ème Conférence annuelle Evercore ISI HealthCONx le 4 décembre à 7h00 PST.
Les webcasts audio en direct des présentations seront accessibles via le site Web des investisseurs de BioMarin, avec des versions archivées disponibles pour une relecture ultérieure.
BioMarin Pharmaceutical (NASDAQ: BMRN) hat seine Teilnahme an drei wichtigen Investorenkonferenzen im November und Dezember 2024 angekündigt. Das Unternehmen wird am 12. November um 11:00 Uhr PST auf der UBS Global Healthcare Conference, am 19. November um 9:00 Uhr GMT auf der Jefferies London Healthcare Conference und am 4. Dezember um 7:00 Uhr PST auf der 7. jährlichen Evercore ISI HealthCONx Conference präsentieren.
Die Live-Audio-Webcasts der Präsentationen sind über die Investoren-Website von BioMarin zugänglich, mit archivierten Versionen, die für die spätere Wiedergabe verfügbar sind.
- None.
- None.
- UBS Global Healthcare Conference on November 12 at 11:00 am PST
- Jefferies London Healthcare Conference on November 19 at 9:00 am GMT
- 7th Annual Evercore ISI HealthCONx Conference on December 4 at 7:00 am PST
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-investor-conferences-302296955.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
What investor conferences will BioMarin (BMRN) attend in November-December 2024?
How can investors access BioMarin's (BMRN) conference presentations in November 2024?
What time is BioMarin's (BMRN) presentation at the UBS Global Healthcare Conference in November 2024?
Will BioMarin's (BMRN) investor conference presentations be available for replay?
